English
Specials
Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
Lending
Lending
Go PRO Now
Open App
you are here:
Success
Alert
Please select a Day.
Info

Rekvina Laboratories Ltd.

Sector : | Industry : Pharmaceuticals & Drugs
Add to

Stock not traded in BSE.
NSE
MC Essentials
33% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Stock not eligible for rating

Financials
    Ownerships
      Industry Comparison
        Others
          Open 0.00
          Previous Close 0.00
          Volume 0.00
          Value (Lacs) 0.00
          VWAP 0.00
          Beta
          Mkt Cap (Rs. Cr.) 0
          High 0.00
          Low 0.00
          UC Limit 0.00
          LC Limit 0.00
          52 Week High 0.00
          52 Week Low 0.00
          Face Value 0.00
          All Time High 0.00
          All Time Low 0.00
          20D Avg Volume 0
          20D Avg Delivery(%) --
          Book Value Per Share --
          Dividend Yield --
          TTM EPS See historical trend 0.00
          TTM PE See historical trend --
          P/B See historical trend --
          Sector PE 0.00

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          Stock not eligible for rating

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 1.75% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison

          Shareholding Pattern
          • Promoter holding remains unchanged at 41.30% in Jun 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          3 out of 5 years Rekvina Laboratories has given positive returns in October.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          October 17.74% (2016) 10.89% -33.72% (2013) -16.98% -0.25%
          Seasonality Analysis

          News

          Rekvina Labs: Outcome of AGM

          Rekvina Labs: Outcome of AGM

          Oct 02 2017 04:45 PM

          ₹ Earning + See More

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Rekvina Labs

          What's your call on Rekvina Labs today?

          Read 0 investor views

          BUY SELL HOLD
          POST

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          No Data For Bulk Deals.

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Rekvina Labs 4.50 - 2.71 - - 0.00 - 0 0 -0.74
          Sun Pharma 1,670.90 0.75 400,904.88 38.65 5.80 15.13 -11.49 10,980 52,578 0.03
          Divis Labs 6,474.50 5.59 171,877.63 74.53 12.53 14.63 8.96 2,191 9,360 0.00
          Cipla 1,561.80 3.22 126,156.85 23.39 4.45 16.90 -3.53 5,291 27,547 0.00
          Torrent Pharma 3,532.80 -0.50 119,566.01 59.73 15.93 25.17 2.60 1,911 11,516 0.40
          + See More

          About the Company

          Rekvina Laboratories Ltd is committed to provide quality medication at affordable prices to the patients with a view to help bring down the healthcare costs.
          {"success":1,"data":{"address":{"address1":"Paradise Complex 328-329,","address2":"3rd Floor, Sayajigunj,,","city":"Vadodra","state":"Gujarat","pincode":"390005","telephone1":"0265-23016761","telephone2":"0265-2362966","fax1":"0265-","fax2":"","email":"info@rekvinalaboratories.com","web":"http:\/\/www.rekvinalaboratories.com"},"management":[{"name":"Amit Mukesh Shah","designation":"Managing Director"},{"name":"Iiaben Pathak","designation":"Non Exe.Non Ind.Director"},{"name":"Chetanbhai Patel","designation":"Independent Director"},{"name":"Dhruvalkumar Patel","designation":"Independent Director"},{"name":"Surbhit Shah","designation":"Executive Director & CFO"}],"registrars":{"name":"Purva Sharegistry (india) Pvt. Ltd.","address1":"No.9, Ground Floor,\nShiv Shakti Industrial Estate,","address2":"","address3":"","address4":"","telephone":"022-23016761, 23018261","fax":"022-23012517","email":"support@purvashare.com","internet":"http:\/\/www.purvashare.com","city":"Mumbai","state":"Maharashtra","pincode":"400011"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"526075","nseId":"","series":"","isinid":"INE092O01028"}}}

          • Registered Office

          • Registrars

          • Management

            • Amit Mukesh Shah

              Managing Director

            • Iiaben Pathak

              Non Exe.Non Ind.Director

            • Chetanbhai Patel

              Independent Director

            • Dhruvalkumar Patel

              Independent Director

            • Surbhit Shah

              Executive Director & CFO

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              526075

            • NSE:

            • Series

            • ISIN

              INE092O01028

          Go to Top
          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347